MARSHALL WACE, LLP - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 197 filers reported holding ANI PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,172,741
+837.9%
89,093
+769.5%
0.01%
+900.0%
Q2 2023$551,542
+24.0%
10,246
-8.5%
0.00%0.0%
Q1 2023$444,824
-78.4%
11,199
-74.9%
0.00%
-75.0%
Q4 2021$2,055,000
+28.9%
44,600
+97.3%
0.00%
-50.0%
Q1 2019$1,594,000
+51.8%
22,606
+21.7%
0.01%
+100.0%
Q3 2018$1,050,00018,5780.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 327,929$9,218,0003.24%
Parkman Healthcare Partners LLC 107,911$3,033,0000.89%
Global Alpha Capital Management Ltd. 350,231$9,845,0000.85%
MARATHON CAPITAL MANAGEMENT 75,010$2,109,0000.60%
TANG CAPITAL MANAGEMENT LLC 100,000$2,811,0000.56%
EMERALD ADVISERS, LLC 354,045$9,952,0000.38%
Sio Capital Management, LLC 40,000$1,124,0000.37%
EMERALD MUTUAL FUND ADVISERS TRUST 299,493$8,419,0000.37%
Stonepine Capital Management, LLC 26,060$733,0000.30%
Mitsubishi UFJ Asset Management (UK) Ltd. 23,000$646,530,0000.29%
View complete list of ANI PHARMACEUTICALS INC shareholders